-
Strategic Partnership with M20 Genomics, Advancing Single-Cell Multi-Omics for Precision Medicine
August 20, 2024 | BALTIMORE – Complete Omics is thrilled to announce an electrifying partnership with M20 Genomics, a trailblazer in single-cell and spatial transcriptomics! Together, these industry leaders are…
-
Exciting News | Valid-NEO® Platform Secures U.S. Patent
May 12, 2024 | BALTIMORE – Complete Omics is thrilled to announce that our Valid-NEO® platform’s “Method and System for Neoantigen Analysis” has been granted a U.S. patent after a rigorous…
-
Complete Omics Inc. Proudly Welcomes Proteomics Luminary Dr. Hui Zhang as Chief Scientific Officer
January 12, 2024 | BALTIMORE – Complete Omics’ Clinical Proteomics team are thrilled to announce that Dr. Hui Zhang, a distinguished figure in the realm of proteomics, has joined the…
-
Securing a Brighter Future: Celebrating Our Investment from Qiming Venture Partners
November 25, 2023 | BALTIMORE – Complete Omics management team are thrilled to announce a significant milestone for our company – a recent investment by Qiming Venture Partners. This partnership…
-
Complete Omics Inc. Founder Qing Wang Featured on Wharton Business School’s Official Website
July 27, 2023 | BALTIMORE – Complete Omics is proud to announce a momentous occasion for Complete Omics Inc.: our visionary founder, Qing Wang, has been featured on the prestigious…